The Brave New World of clinical cancer research: Adaptive biomarker‐driven trials integrating clinical practice with clinical research
Open Access
- 11 March 2015
- journal article
- review article
- Published by Wiley in Molecular Oncology
- Vol. 9 (5) , 951-959
- https://doi.org/10.1016/j.molonc.2015.02.011
Abstract
Clinical trials are the final links in the chains of knowledge and for determining the roles of therapeutic advances. Unfortunately, in an important sense they are the weakest links. This article describes two designs that are being explored today: platform trials and basket trials. Both are attempting to merge clinical research and clinical practice.Keywords
This publication has 19 references indexed in Scilit:
- Multicompany trials adapt to disciplines beyond cancerNature Medicine, 2014
- Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trialsClinical Trials, 2013
- Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center InitiativeClinical Cancer Research, 2012
- Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657Journal of Clinical Oncology, 2012
- Reports from the 2010 Clinical and Translational Cancer Research Think Tank Meeting: Design Strategies for Personalized Therapy TrialsClinical Cancer Research, 2012
- Adaptive clinical trials in oncologyNature Reviews Clinical Oncology, 2011
- The BATTLE Trial: A Bold Step toward Improving the Efficiency of Biomarker-Based Drug DevelopmentCancer Discovery, 2011
- The BATTLE Trial: Personalizing Therapy for Lung CancerCancer Discovery, 2011
- Detecting an Overall Survival Benefit that Is Derived From Progression-Free SurvivalJNCI Journal of the National Cancer Institute, 2009
- Bayesian clinical trialsNature Reviews Drug Discovery, 2006